To what Extent are The Learnings from The Introduction of Biosimilars in Inflammatory Diseases Transferable to The Future Introduction of Biosimilars in Oncology?
Abstract
Authors
S Klebba D Makin CW Teale
S Klebba D Makin CW Teale
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now